Cases & Investigations

Weyerhaeuser Lawsuit: TJI Joists with Flak Jacket

Berger Montague has filed class action complaints in Colorado, Delaware, New Jersey, New York, Minnesota, and Pennsylvania on behalf of consumers who purchased Weyerhaeuser’s TJI Joists with Flak Jacket. People who have this joist in their homes have reported that it produces an odor and may suffer from other defects in its formulation.

Whitney v. Turner/Time Warner

Berger Montague settled this individual claim for a confidential amount, seeking interpretation of the distribution agreement for the movie Gone with the Wind and undistributed profits for the years 1993-1997, with forward changes in accounting and distribution.

Workers’ Compensation Insurance Lawsuit Against Applied Underwriters

Berger Montague is representing proposed classes of California and New York employers who participated in Applied Underwriters Inc.’s EquityComp or SolutionOne workers compensation insurance at any time between January 1, 2006 and the present.

Xarelto Class Action Lawsuit Investigation

The attorneys at Berger Montague are reviewing claims on behalf of patients who took Xarelto, a blood-thinning drug that has been linked to hundreds of serious injuries and deaths. If you or a loved one suffered a serious bleeding event after taking Xarelto, call Berger Montague to speak to an attorney today, free of charge.

  • Under Investigation
  • Defective Drugs & Medical Devices
  • Read More >

Xcel Energy Inc. Securities, Derivative & ERISA Litigation

Berger Montague, as co-lead counsel in the securities actions, obtained a cash settlement of $80 million on behalf of investors against Xcel Energy and certain of its officers and directors.

  • Settled
  • Employee Benefits & ERISA, Securities & Investor Protection
  • Read More >

Zetia Antitrust Litigation

Berger Montague represents a proposed class of direct purchasers of the drug Zetia (ezetimibe). Plaintiffs allege that Merck & Co. Inc., Merck Sharp & Dohme Corp., Schering-Plough Corp., Schering Corp., MSP Singapore Co. LLC (collectively, “Merck”), Glenmark Pharmaceuticals LTD, and Glenmark Generics Inc. (together, “Glenmark”) entered into a reverse payment agreement that delayed generic competition to Merck’s brand cholesterol drug Zetia.

Go to page: 1 29 30 31

Request A Free Consultation

  • This field is for validation purposes and should be left unchanged.